Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study

Danny R. Youlden, Kiarash Khosrotehrani, Adèle C. Green, H. Peter Soyer, Michael G. Kimlin, Philippa H. Youl, Joanne F. Aitken, Peter D. Baade

Research output: Contribution to journalArticle

Abstract

Using a large (N= 25 493) population-based cohort from Queensland, Australia, we compared melanoma survival among cases with a single invasive melanoma only against those who also had a diagnosis of a single in situ melanoma. After adjustment for sex, age, body site, clinicopathological subtype, thickness and ulceration, it was found that there was no difference (P = 0.99) in 10-year melanoma-specific mortality following a diagnosis of an invasive lesion, whether or not an in situ melanoma was also present. We conclude that in situ melanomas do not alter the prognosis of an invasive melanoma.

Original languageEnglish
Pages (from-to)57-60
Number of pages4
JournalAustralasian Journal of Dermatology
Volume57
Issue number1
DOIs
Publication statusPublished - 1 Feb 2016
Externally publishedYes

Fingerprint Dive into the research topics of 'Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study'. Together they form a unique fingerprint.

  • Cite this

    Youlden, D. R., Khosrotehrani, K., Green, A. C., Soyer, H. P., Kimlin, M. G., Youl, P. H., Aitken, J. F., & Baade, P. D. (2016). Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study. Australasian Journal of Dermatology, 57(1), 57-60. https://doi.org/10.1111/ajd.12429